Part 1/13:
The Bizarre Saga of Sinovac: From Corporate Governance Battles to Pandemic Windfalls
The story of Sinovac, a Chinese vaccine developer, is a tale woven with corporate intrigue, legal battles, and an extraordinary financial windfall brought about by the COVID-19 pandemic. This long-overdue narrative sheds light on how a company entangled in complex governance disputes and legal controversies ended up sitting on a treasure trove of cash, yet remained largely inaccessible to its shareholders for over six years.